Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds
- PMID: 1121004
- DOI: 10.1021/jm00238a011
Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds
Abstract
A synthetic study was made on the active metabolite of cyclophosphamide. Ozonolysis of O-(3 butenyl)-N,N-bis(2-chloroethyl)phosphorodiamidate, prepared by reaction of POC13 with 3-buten-1-ol followed by treatment with N,N-bis(2-chloroethyl)amine (nor mustard) and NH3, afforded 2-[bis(2-chloroethyl)amino]-4-hydroperoxytetrahydro-2H-1, 3,2-oxazaphosphorine 2-oxide (4-hydroperoxycyclophosphamide). Deoxygenation of 4-hydroperoxycyclophosphamide by triphenylphosphine yielded 4-hydroxycyclophosphamide in a pure crystalline state. These products exhibited high cytostatic activity in both in vitro and in vivo experiments. The results give confirmatory evidence for the hypothesis that C4-hydroxylation on the 1,3,2-oxazaphosphorinane ring of cyclophosphamide is necessary for its activation.
Similar articles
-
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.Br J Cancer. 1983 Jan;47(1):15-26. doi: 10.1038/bjc.1983.2. Br J Cancer. 1983. PMID: 6821629 Free PMC article.
-
Synthesis and antitumor activity of cyclophosphamide analogs. 1. Benzo annulated cyclophosphamide and related systems.J Med Chem. 1975 Dec;18(12):1251-3. doi: 10.1021/jm00246a017. J Med Chem. 1975. PMID: 1195278
-
Cyclophosphamide. Complete inhibition of murine leukemia L1210 in vivo by a Fenton oxidation product.J Am Chem Soc. 1974 Jan 9;96(1):313-5. doi: 10.1021/ja00808a082. J Am Chem Soc. 1974. PMID: 4810573 No abstract available.
-
Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.Cancer Treat Rep. 1976 Apr;60(4):301-8. Cancer Treat Rep. 1976. PMID: 1277205
-
Ifosfamide in experimental tumor systems.Semin Oncol. 1982 Dec;9(4 Suppl 1):14-23. Semin Oncol. 1982. PMID: 6761864 Review. No abstract available.
Cited by
-
Preclinical pharmacokinetics and stability of isophosphoramide mustard.Cancer Chemother Pharmacol. 1994;33(5):391-8. doi: 10.1007/BF00686268. Cancer Chemother Pharmacol. 1994. PMID: 8306413
-
Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.J Endocrinol. 2019 Feb 1;240(2):243-256. doi: 10.1530/JOE-18-0370. J Endocrinol. 2019. PMID: 30530902 Free PMC article.
-
[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].J Cancer Res Clin Oncol. 1980 Jan;96(1):79-92. doi: 10.1007/BF00412899. J Cancer Res Clin Oncol. 1980. PMID: 7358774 Free PMC article. German.
-
Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide.Pharm Res. 1984 Mar;1(2):89-92. doi: 10.1023/A:1016307515811. Pharm Res. 1984. PMID: 24277218
-
Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.Eur J Clin Pharmacol. 1981;19(6):443-51. doi: 10.1007/BF00548589. Eur J Clin Pharmacol. 1981. PMID: 7250178
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous